Medicare Enrolled
Dr. David Tschopp, MD
Cardiovascular Disease · Austin, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tschopp from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tschopp? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tschopp
Dr. David Tschopp is a cardiovascular disease in Austin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Tschopp performed 7,655 Medicare services across 4,353 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tschopp received a total of $119,242 from 34 pharmaceutical and/or device companies across 1361 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tschopp is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 6% volume in TX$ $119,242 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,655
Medicare services
Top 6% in TX for cardiovascular disease
4,353
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~403 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote pacemaker/defibrillator monitoring, 90 days | 1,548 | $18 | $98 |
| Electrocardiogram (EKG), 12-lead | 1,361 | $11 | $60 |
| Office visit, established patient (30-39 min) | 1,099 | $93 | $206 |
| Remote pacemaker monitoring, 90 days | 1,051 | $22 | $106 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 513 | $27 | $207 |
| Programming of dual lead pacemaker system | 379 | $60 | $187 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 197 | $28 | $144 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 195 | $19 | $85 |
| Office visit, established patient, complex (40-54 min) | 136 | $135 | $278 |
| Programming of multiple lead implantable defibrillator system | 109 | $83 | $286 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 81 | $17 | $79 |
| Programming of dual lead implantable defibrillator system | 77 | $69 | $256 |
| New patient office visit (30-44 min) | 73 | $75 | $208 |
| Office visit, established patient (10-19 min) | 72 | $40 | $84 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 66 | $241 | $1,229 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 66 | $742 | $3,279 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 56 | $373 | $1,699 |
| Programming of multiple lead pacemaker system | 54 | $58 | $217 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 54 | $59 | $866 |
| Heart rhythm recording of continous external ekg over 8-15 days | 52 | $10 | $45 |
| Repair of left upper heart chamber with implant with review by radiologist | 41 | $610 | $2,519 |
| External shock to heart to regulate heart beat | 39 | $85 | $390 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 39 | $241 | $1,230 |
| New patient office visit (45-59 min) | 37 | $118 | $320 |
| New patient office visit, complex (60-74 min) | 28 | $172 | $398 |
| Office visit, established patient (20-29 min) | 27 | $69 | $139 |
| Hospital follow-up visit, moderate complexity | 27 | $57 | $141 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 25 | $363 | $1,487 |
| Programming of single lead pacemaker system | 24 | $53 | $159 |
| EKG interpretation and report | 22 | $7 | $27 |
| Insertion of implantable defibrillator system | 20 | $722 | $2,943 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 20 | $656 | $2,457 |
| Programming of heart rhythm stimulation after drug infusion | 19 | $67 | $585 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 12 | $19 | $72 |
| Insertion of tube in left heart chamber through heart septum | 12 | $162 | $626 |
| Destruction of heart conduction tissue to create heart block | 12 | $457 | $1,901 |
| Initial hospital admission, moderate complexity | 12 | $104 | $268 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
52.6% high complexity
0.7% medium
46.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$119,242
Total received (2018-2024)
Avg $17,035/year across 7 years
Top 5% in TX for cardiovascular disease
34
Companies
1,361
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$74,321 (62.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$27,771 (23.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17,150 (14.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$7,808
2023$10,594
2022$31,079
2021$28,689
2020$15,912
2019$10,307
2018$14,855
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$30,052
ATRICURE, INC.
$29,206
AtriCure, Inc.
$26,502
PFIZER INC.
$12,925
E.R. Squibb & Sons, L.L.C.
$6,411
Biosense Webster, Inc.
$5,526
Janssen Pharmaceuticals, Inc
$2,500
BOSTON SCIENTIFIC CORPORATION
$1,738
SANOFI-AVENTIS U.S. LLC
$752
Boston Scientific Corporation
$739
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$643
Impulse Dynamics (USA) Inc.
$499
Medtronic Vascular, Inc.
$364
CVRx, Inc.
$280
Aziyo Biologics, Inc.
$157
CARDIVA MEDICAL, INC.
$144
iRhythm Technologies, Inc.
$130
ABIOMED
$107
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Vital Connect, Inc
$80
CardioFocus, Inc.
$63
Medtronic, Inc.
$63
Terumo Medical Corporation
$56
Alnylam Pharmaceuticals Inc.
$29
Davol Inc.
$29
Baxter Healthcare
$25
Innovation Technologies Inc
$19
Lundbeck LLC
$18
JAZZ PHARMACEUTICALS INC.
$18
Ethicon US, LLC
$17
Amgen Inc.
$16
G Medical Diagnostic Services, Inc.
$15
ConvaTec Inc.
$12
Novartis Pharmaceuticals Corporation
$11
Top 3 companies account for 71.9% of total payments
Associated products mentioned in payments ›
AGILIS · AMPLATZER · AMPLATZER AMULET · AMPLATZER Occluders · ARISTA AH FLEXITIP · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE ATRICLIP LAA EXCLUSION · ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM · AVEIR · AZUR · Accent Pacemaker · Advisa · Advisor Catheter · Agilis NxT EP Introducer · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Ampere RF Ablation Generator · Amplia MRI · Arctic Front · Assurity Pacemaker · Avelle NPWT · BRK EP Transseptal Access · Barostim Neo System · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · CONFIRM RX · Cardiac Monitoring Suite · CardioMEMS HF System · Carto 3 · Carto 3 System · Carto 3 System RMT · Carto Smarttouch · CartoSound · Cartomerge · Cartoreplay · Cobalt · Cobra Fusion Ablation System · Confidense · Confirm Rx · Corlanor · DURATA · ECM · ECM Patch · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · EP-WorkMate Claris System · EPI-SENSE GUIDED COAGULATION SYS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FORTIFY ASSURA · FUSION ABLATION SYSTEM · FlexAbility Ablation Catheter · Fortify Assura · GALLANT · GENERAL THERAPIES · GENERAL THERAPIES · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL THERAPIES · INGEVITY · IRRISEPT · Impella · Inquiry Steerable Catheters · JOT DX · LARIAT RS · LARIAT SUTURE DELIVERY DEVICE · LINX Reflux Management System · LUX-DX · LifeVest · MERLIN@HOME · MODELS · MULTAQ · Merlin Connectivity and Remote · MetaCross · Micra · NA · NORTHERA · NUVISION ICE CATHETER · Navistar · OCTARAY MAPPING CATHETER · ONPATTRO · OPTIMIZER · OPTIMIZER SMART SYSTEM · Optimizer · Optimizer Smart System · PRADAXA · PREVELEAK · Paso · Pentaray · Pouch · QDOT MICRO Catheter · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESONATE · SENSOR ENABLED · SYNERGY ABLATION SYSTEM · SmartAblateTM System RF Generator · Soundstar · SureFix · TACTICATH ABLATION CATHETER · TENDRIL · Tendril Pacing Lead · Unify Assura CRT Defibrillator · VIEWMATE · VISITAG SURPOINT External Processing Unit · VITALPATCH RTM · VYNDAQEL · Vascular Closure Device · ViewFlex Xtra ICE Catheter · ViewMate Intracardiac Echo · Visia AF · Viva · WATCHMAN · XARELTO · XYREM · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for cardiovascular disease in TX.
Equivalent to $1,558 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
92
Per 100K population
7.0
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tschopp is a electrophysiology & remote specialist, with above-average Medicare volume (top 6% in TX), and high industry engagement (low-engagement, top 5%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tschopp experienced with remote pacemaker/defibrillator monitoring, 90 days?
Based on Medicare claims data, Dr. Tschopp performed 1,548 remote pacemaker/defibrillator monitoring, 90 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tschopp receive payments from pharmaceutical companies?
Yes. Dr. Tschopp received a total of $119,242 from 34 companies across 1,361 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tschopp's costs compare to other cardiovascular diseases in Austin?
Dr. Tschopp's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tschopp) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Austin
Browse cardiovascular diseases in Austin ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ATRICURE, INC. Payments to Doctors
See all physicians who received payments from ATRICURE, INC..
By company
AtriCure, Inc. Payments to Doctors
See all physicians who received payments from AtriCure, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology